Evidence map›Paper›PMID 41421004›Full record

ReviewInternational dental journal2026

FDA-Approved AI Solutions in Dental Imaging: A Narrative Review of Applications, Evidence, and Outlook.

Sohaib Shujaat, Hend Aljadaan, Hessah Alrashid, Ali Anwar Aboalela, Marryam Riaz

Abstract readReview
In one paragraph

Review in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sohaib ShujaatKing Abdullah International Medical Research Center, Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. Electronic address: sohaib.shujaat941@gmail.com.
Hend AljadaanKing Abdullah International Medical Research Center, College of Dentistry, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Hessah AlrashidKing Abdullah International Medical Research Center, College of Dentistry, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Ali Anwar AboalelaKing Abdullah International Medical Research Center, Department of Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Marryam RiazDepartment of Physiology, Azra Naheed Dental College, Superior University, Lahore, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

aimsArtificial intelligence (AI) has rapidly transformed dental imaging by enabling automated detection, diagnosis, and analysis of various dental conditions. However, a comprehensive synthesis of United States Food and Drug Administration (FDA)-cleared, clinically validated AI solutions in dental imaging remains limited. This review aims to catalog all standalone, cloud-based dental AI platforms with FDA clearance, highlighting their clinical applications, performance outcomes, and supporting evidence to guide evidence-based integration.

methodsA two-phase systematic search was conducted. In the first phase, searches of U.S. FDA regulatory databases (510[k], De Novo, and PMA) were performed through July 2025 to identify standalone, cloud-based dental AI imaging devices cleared or authorized for autonomous or semi-autonomous analysis. In the second phase, PubMed, Web of Science, and Google Scholar were systematically searched to retrieve studies assessing the performance or clinical utility of the identified platforms. Two independent reviewers performed data screening and extraction, with discrepancies resolved by a third reviewer.

resultsThirteen companies were identified as offering twenty-nine FDA-cleared AI products for dental imaging. These solutions addressed diverse clinical tasks, including caries detection, periodontal disease assessment, cephalometric analysis, multi-pathology diagnostics, automated dental charting, and three-dimensional segmentation. Performance outcomes reported by the FDA demonstrated high accuracy, sensitivity, and specificity across most platforms, particularly for caries detection, periodontal disease measurement, and cephalometric analysis. Among these, Relu Creator and WebCeph were supported by the highest number of peer-reviewed publications, whereas several newer platforms lacked independent clinical validation.

conclusionStandalone, FDA-cleared AI platforms represent a paradigm shift in dental imaging, providing clinically validated tools for diagnosis, treatment planning, and patient monitoring. By systematically cataloging these solutions, this review delivers an evidence-based reference for clinicians and researchers, supporting informed adoption and identifying areas for future investigation.

Indexed as

Artificial IntelligenceDental CariesHumansUnited StatesUnited States Food and Drug AdministrationArtificial IntelligenceCloud ComputingDental ImagingDiagnostic ImagingUnited States Food and Drug Administration

Identifiers

PMID41421004
PMCPMC12775797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.